VYNE Therapeutics Inc. (VYNE) Stock Price History
Historical prices from 2018 to 2026
Loading 10-year price history...
VYNE Historical Performance
Short-Term Returns
VYNE Stock Price Trajectory (2018–2026)
As of May 8, 2026, VYNE Therapeutics Inc. (VYNE) trades at $0.67, representing a -50.8% return over the past year. The stock has delivered a -99.0% total return over five years (-59.9% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $2,869.92 on February 6, 2018. From this peak, VYNE has corrected -100.0%, currently trading 36% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers DERM (-28.1% 1Y), PRGO (-55.6% 1Y), and SKIN (-35.9% 1Y), VYNE has underperformed the peer group average. Compare VYNE vs DERM →
VYNE Historical Price Data (2025–2026)
Showing 30 of 2,083 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 0.67 | 0.68 | 0.67 | 0.67 | 229K | +0.58% |
| 2026-05-06 | 0.67 | 0.68 | 0.65 | 0.67 | 190K | +0.53% |
| 2026-05-05 | 0.67 | 0.69 | 0.66 | 0.67 | 452K | +1.54% |
| 2026-05-04 | 0.64 | 0.66 | 0.64 | 0.66 | 1.57M | +2.31% |
| 2026-05-01 | 0.64 | 0.64 | 0.64 | 0.64 | 105K | +0.71% |
| 2026-04-30 | 0.62 | 0.65 | 0.62 | 0.64 | 37K | +0.13% |
| 2026-04-29 | 0.63 | 0.65 | 0.63 | 0.64 | 28K | -0.63% |
| 2026-04-28 | 0.64 | 0.65 | 0.62 | 0.64 | 111K | +0.22% |
| 2026-04-27 | 0.65 | 0.65 | 0.64 | 0.64 | 27K | -1.02% |
| 2026-04-24 | 0.64 | 0.65 | 0.63 | 0.65 | 77K | +0.77% |
| 2026-04-23 | 0.65 | 0.65 | 0.64 | 0.64 | 32K | -1.10% |
| 2026-04-22 | 0.63 | 0.65 | 0.63 | 0.65 | 45K | +1.16% |
| 2026-04-21 | 0.63 | 0.64 | 0.63 | 0.64 | 148K | +1.06% |
| 2026-04-20 | 0.61 | 0.64 | 0.61 | 0.63 | 441K | +3.79% |
| 2026-04-17 | 0.62 | 0.63 | 0.61 | 0.61 | 183K | -1.21% |
| 2026-04-16 | 0.61 | 0.63 | 0.61 | 0.62 | 85K | -0.37% |
| 2026-04-15 | 0.62 | 0.63 | 0.60 | 0.62 | 59K | -0.48% |
| 2026-04-14 | 0.61 | 0.63 | 0.61 | 0.62 | 84K | -0.30% |
| 2026-04-13 | 0.61 | 0.62 | 0.61 | 0.62 | 42K | +2.43% |
| 2026-04-10 | 0.61 | 0.61 | 0.60 | 0.61 | 101K | -0.41% |
| 2026-04-09 | 0.62 | 0.62 | 0.60 | 0.61 | 38K | +0.41% |
| 2026-04-08 | 0.59 | 0.63 | 0.59 | 0.61 | 92K | +2.87% |
| 2026-04-07 | 0.61 | 0.62 | 0.59 | 0.59 | 47K | -3.98% |
| 2026-04-06 | 0.61 | 0.62 | 0.60 | 0.62 | 169K | +2.76% |
| 2026-04-02 | 0.61 | 0.61 | 0.59 | 0.60 | 118K | -0.83% |
| 2026-04-01 | 0.60 | 0.62 | 0.59 | 0.61 | 120K | +1.42% |
| 2026-03-31 | 0.58 | 0.60 | 0.58 | 0.60 | 149K | +1.62% |
| 2026-03-30 | 0.59 | 0.59 | 0.57 | 0.59 | 133K | -0.54% |
| 2026-03-27 | 0.62 | 0.62 | 0.59 | 0.59 | 134K | -4.26% |
| 2026-03-26 | 0.61 | 0.63 | 0.60 | 0.62 | 251K | +0.23% |
See VYNE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VYNE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VYNE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVYNE — Frequently Asked Questions
Quick answers to the most common questions about buying VYNE stock.
How has VYNE stock performed recently?
VYNE declined -50.8% over the past year, below its 5-year annualized CAGR of -59.9%. The stock trades above its 200-day moving average, reflecting the downtrend.
What is VYNE's all-time high price?
VYNE Therapeutics Inc. reached $2869.92 on 2018-02-06. The 52-week high is $1.96. Current 1-year return of -50.8% places the stock further from historical peaks.
Where can I download VYNE historical price data?
This page provides VYNE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2018-2026, downloadable in CSV format.